Action grants for ‘Cancer Diagnostic and Treatment for All’ including ‘Genomic for Public Health’

Last updated: 18.7.2025
Grant

This program offers action grants under the EU4Health Programme, specifically targeting 'Cancer Diagnostic and Treatment for All' and 'Genomic for Public Health'. Its main purpose is to enhance access to personalized cancer prevention, diagnosis, and treatment across the Union. The initiative aims to upscale available innovation and translate genomic research into tangible public health measures.

Who is Funded by the EU4Health Cancer Grants

This section outlines the eligibility criteria for applicants, the geographical scope of the program's activities, and its core objectives. It details who can apply, where projects should be implemented, and the strategic goals the program aims to achieve.

What is Funded under 'Cancer Diagnostic and Treatment for All' & 'Genomic for Public Health'

This section provides details on the types of projects and activities eligible for funding, including the thematic areas, supported developmental stages, and rules regarding eligible and excluded costs.

Type and Scope of Funding for Cancer & Genomics Initiatives

This section details the financial aspects of the 'Cancer Diagnostic and Treatment for All' and 'Genomic for Public Health' grants, including the type of financial instrument, the total budget available for this topic, the funding rate, and the recommended project duration.

Conditions and Requirements for EU Cancer & Genomics Grants

This section outlines the essential rules and specific conditions that applicants and beneficiaries must adhere to throughout the application and project implementation phases for these cancer and genomics focused grants. It covers application terms, budget stipulations, and other key provisions.

Application Procedure for EU Cancer Grants

This section provides a guide to the application process for the 'Cancer Diagnostic and Treatment for All' and 'Genomic for Public Health' grants, from submission to evaluation and award. It outlines the step-by-step procedure and how decisions are made.

This section details the fundamental legal and official documents that provide the authority and framework for the 'Cancer Diagnostic and Treatment for All' and 'Genomic for Public Health' funding program. It identifies the core legal acts and other key regulations that govern its implementation.

Similar Programs

#EU4Health Cancer Grants#Genomic Public Health#Personalized Cancer Treatment#Cancer Diagnosis#Cancer Prevention#Next Generation Sequencing#EU Funding#Health Innovation#European Health Data#Medical Technology#Action Grants#Research and Development#Public Health Policy#Genetic Profiling#EU4H-2021-PJ-15#Cancer Care

Funding Overview

Funding Status

Funding Status:

Closed

Maximum Amount

Maximum Amount:

6,000,000 €

Allocated Budget

Allocated Budget:

6,000,000 €

Deadline

Deadline:

25.01.2022

Award Channel

Award Channel:

Individual Aid

Region

Region:

EU Member States, EEA countries, or countries associated with the EU4Health Programme.

Sectors

Sectors:

Healthcare, Medical Technology, Research and Development, Environmental and Climate Protection

Beneficiaries

Beneficiaries:

Individuals and cancer patients and survivors

Application Type

Application Type:

Optional Consortium

Funding Stages

Funding Stages:

Applied Research, Pilot Testing, Product Development, Process Optimization, Market Introduction, Implementation, Service Delivery

Funding Provider

Program Level:

European Union

Funding Body:

European Union

Managed By:

European Health and Digital Executive Agency (HaDEA)

0 x 0
XS